← SynDRA
TABIMORELIN
SynDRA canonical compound SYN0001474 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | GH1 | GHRHR | GHSR |
| Mechanism of action | growth hormone secretagogue receptor agonist |
All known targets
Mechanisms of action (all sources)
- GHSR AGONIST
- Ghrelin receptor agonist
- CYP3A4 INHIBITOR
- Cytochrome P450 3A4 inhibitor
- growth hormone secretagogue receptor agonist
- GHSR MODULATOR
Cross-references
Synonyms
- Tabimoreline
- Tabimorelina
- Nn703
- NN-703
- NNC-26-0703
- N-[5-Amino-5-methyl-2(E)-hexenoyl]-N-methyl-3-(2-naphthyl)-D-alanyl-N-methyl-D-phenylalanine methylamide
- NN 703
- L51CBE03KF
- tabimorelina
- tabimoreline
- tabimorelinum
- RefChem:187089
- DTXCID901513685
- Tabimorelin [INN]
- UNII-L51CBE03KF
- TABIMORELIN [WHO-DD]
- SCHEMBL209441
- SCHEMBL29440097
- SCHEMBL29899698
- WURGZWOTGMLDJP-ZCYANPAGSA-N
- BDBM50066816
- MSK001681
- MSK001681-100M
- NCGC00092365-01
- HY-121580
- CS-0082772
- Tabimorelin Solution in Methanol, 100ug/mL
- BRD-K53600683-051-01-5
- C68H84N8O10
- HMS3677E06
- Tabimorelin hemifumarate
- HMS3413E06
- orb1704018
- EX-A15332
- DA-58234
- MFCD08703111
- AKOS024457042
- T23413
Look up TABIMORELIN in the interactive SynDRA portal →